Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henit Yanai

Showing results (71-80 of 128) with videos related to

Pageof 13
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 13, 2025
Drug persistence of first- and advanced-line therapy for chronic inflammatory pouch disorders: A prospective cohort spanning sequential treatment linesMaya Fischman, Lihi Godny, Adi Friedenberg, et al.
Harefuah|April 25, 2022
[CUFFING PRISONERS AND DETAINEES IN ISRAELI HOSPITALS - A MULTI-CENTER STUDY]Nitai Bar, Efrat Naaman, Amit Asa, et al.
Gut|April 6, 2018
Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBDRenaud Gaujoux, Elina Starosvetsky, Naama Maimon, et al.
Inflammatory Bowel Diseases|May 20, 2024
Predictors of Complicated Disease Course in Children and Adults With Ulcerative Colitis: A Nationwide Study From the epi-IIRNOhad Atia, Rachel Buchuk, Rona Lujan, et al.
Journal of Crohn'S & Colitis|November 18, 2021
Improved Outcomes of Paediatric and Adult Crohn's Disease and Association With Emerging Use of Biologics-A Nationwide Study From the Epi-IIRNOhad Atia, Esther Orlanski-Meyer, Rona Lujan, et al.
Lancet (London, England)|July 17, 2023
Shackling incarcerated people in Israeli hospitals-a multicentre study followed by a national intervention programmeNitai Bar, Efrat Naaman, Danny Rosin, et al.
Journal of Crohn'S & Colitis|July 19, 2015
Cogan's Syndrome in Patients With Inflammatory Bowel Disease--A Case SeriesStephan R Vavricka, Thomas Greuter, Michael Scharl, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 3, 2024
Precision medicine: Externally validated explainable AI support tool for predicting sustainability of infliximab and vedolizumab in ulcerative colitisTom Konikoff, Nadav Loebl, Henit Yanai, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2014
Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumabHenit Yanai, Lev Lichtenstein, Amit Assa, et al.
Gastroenterology|March 19, 2025
Capsule Endoscopy-Guided Proactive Treat-to-Target Versus Continued Standard Care in Patients With Quiescent Crohn's Disease: A Randomized Controlled TrialShomron Ben-Horin, Adi Lahat, Bella Ungar, et al.
Pageof 13

Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 13, 2025
Drug persistence of first- and advanced-line therapy for chronic inflammatory pouch disorders: A prospective cohort spanning sequential treatment linesMaya Fischman, Lihi Godny, Adi Friedenberg, et al.
Harefuah|April 25, 2022
[CUFFING PRISONERS AND DETAINEES IN ISRAELI HOSPITALS - A MULTI-CENTER STUDY]Nitai Bar, Efrat Naaman, Amit Asa, et al.
Gut|April 6, 2018
Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBDRenaud Gaujoux, Elina Starosvetsky, Naama Maimon, et al.
Inflammatory Bowel Diseases|May 20, 2024
Predictors of Complicated Disease Course in Children and Adults With Ulcerative Colitis: A Nationwide Study From the epi-IIRNOhad Atia, Rachel Buchuk, Rona Lujan, et al.
Journal of Crohn'S & Colitis|November 18, 2021
Improved Outcomes of Paediatric and Adult Crohn's Disease and Association With Emerging Use of Biologics-A Nationwide Study From the Epi-IIRNOhad Atia, Esther Orlanski-Meyer, Rona Lujan, et al.
Lancet (London, England)|July 17, 2023
Shackling incarcerated people in Israeli hospitals-a multicentre study followed by a national intervention programmeNitai Bar, Efrat Naaman, Danny Rosin, et al.
Journal of Crohn'S & Colitis|July 19, 2015
Cogan's Syndrome in Patients With Inflammatory Bowel Disease--A Case SeriesStephan R Vavricka, Thomas Greuter, Michael Scharl, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 3, 2024
Precision medicine: Externally validated explainable AI support tool for predicting sustainability of infliximab and vedolizumab in ulcerative colitisTom Konikoff, Nadav Loebl, Henit Yanai, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2014
Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumabHenit Yanai, Lev Lichtenstein, Amit Assa, et al.
Gastroenterology|March 19, 2025
Capsule Endoscopy-Guided Proactive Treat-to-Target Versus Continued Standard Care in Patients With Quiescent Crohn's Disease: A Randomized Controlled TrialShomron Ben-Horin, Adi Lahat, Bella Ungar, et al.
Pageof 13